A federal judge dismissed two co-defendants from the Androderm testosterone products liability MDL last week. One, the parent company of the other Actavis defendants, was dismissed for having no actionable role in the Androderm issue. The other, Watson Laboratories, Inc., a Nevada Corporation, was dismissed because it was named in error. Its name is virtually identical to that of the properly named co-defendant, Watson Laboratories, Inc. a DELAWARE Corporation. Watson Delaware is now called Actavis Laboratories UT, Inc.